Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DuPont de Nemours Inc (DD) vs EPAM Systems Inc (EPAM) Price & Performance

DuPont de Nemours IncTrade
EPAM Systems IncTrade

Price performance (Past 24H)

Key statistics

DuPont de Nemours Inc vs EPAM Systems Inc — how do they compare? DuPont de Nemours Inc trades at $134.41 (market cap $18.12B), while EPAM Systems Inc trades at $84.99 (market cap $4.41B). The key difference: DuPont de Nemours Inc is far larger — about 4.1× EPAM Systems Inc's market cap, and DuPont de Nemours Inc pays a 1.79% dividend while EPAM Systems Inc pays none. Which is the better fit depends on your goals.

DDEPAM
Market Cap
$18.12B$4.41B
Sector
Basic MaterialsTechnology
52-Week High
$154.59$221.40
52-Week Low
$87.72$76.04
Enterprise Value
$20.58B$3.67B
Dividend Yield
1.79%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DuPont de Nemours Inc

DuPont (DD) trades at $132.66, down 1.5% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong gross margins (35.01%) but negative net income margin (-0.42%) and ROE (-0.16%). Analyst consensus remains bullish with a $227.20 price target (71% upside), though the company faces legal challenges and persistent net cash outflows. Recent developments include water technology upgrades and a 3:1 reverse stock split effective June 2026.

While analyst optimism and valuation discount to price target suggest potential upside, investors face significant risks including ongoing litigation over 'forever chemicals,' weak profitability trends, and concerning cash flow patterns. The stock's current technical weakness near support levels requires careful monitoring of Q2 2026 earnings results due July 2026.

EPAM Systems Inc

EPAM trades at $86.38, up 2.97% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows attractive valuation with a P/E of 12.41 and P/S of 0.86, supported by consistent earnings beats in recent quarters. Revenue grew to $5.46B in 2025, though net income margin dipped to 6.96%. Recent news highlights EPAM's AI partnerships and upcoming Q2 earnings, with analyst sentiment strongly bullish.

The outlook for EPAM is positive given its low valuation multiples and strong analyst consensus, with a price target of $128.55 implying significant upside. Risks include competitive pressures in IT services and potential margin compression, but the company's focus on AI transformation and solid cash flow generation provide a foundation for growth. Investors should weigh the high institutional confidence against macroeconomic headwinds affecting the tech sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

Read more on DD

About EPAM Systems Inc

EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.

Read more on EPAM